Loading...
Yunkang Group Limited
2325.HK•HKSE
HealthcareMedical - Diagnostics & Research
$3.50
$0.00(0.00%)
Yunkang Group Limited (2325.HK) AI-Powered Stock Analysis
See how Yunkang Group Limited scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerYunkang Group Limited (2325.HK) Stock Overall Grade
Yunkang Group Limited’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
B
Good
Grade Breakdown by Metric
See how each financial and market factor contributes to Yunkang Group Limited's overall stock rating.
Forecast
C+Score
54/100Financial Growth
CScore
40/100Fundamental Growth
CScore
45/100Key Ratios
BScore
64/100Sector Comparison
B+Score
75/100Industry Comparison
B+Score
70/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
C+Score
50/100Component Analysis Explained
Understand the key factors behind each Yunkang Group Limited stock grade, including financials, comparisons, and forecasts.